Where does Taylor Boyd work?

Taylor Boyd is Chief Business Officer at Avalo Therapeutics.

Where did Taylor Boyd go to school?

Taylor Boyd studied at Wake Forest University School of Business (Master's degree, Accounting (Transaction Services)); North Carolina State University (Bachelor of Science (B.S.), Accounting); NOLS (Chilean Patagonia).

Taylor Boyd

Investor

Chief Business Officer at Avalo Therapeutics

Raleigh, North Carolina, United States

Find your path to Taylor

831 people in our graph share verified history with Taylor — schools, employers, funds. One of them is your warm intro.

Ranieri PaternòunlockedTaylor: together at RBC Capital Markets (2014–2016)

×5Taylor: together at KPMG US

×2Taylor: together at NOLS

×2Taylor: together at Grant Thornton LLP

About

Nearly 15 years of biotech business development, corporate finance, and investment banking experience. Recently served as Executive Vice President and Chief Business Officer at Abzena leading M&A and licensing initiatives. Previously VP and Head of Business Development at Longboard Pharmaceuticals (acquired for $2.6 billion by Lundbeck) and held investment banking roles executing over $40 billion in transactions.

Experience

Avalo TherapeuticsChief Business Officercurrent2025 — presentRaleigh, NC
AbzenaChief Business Officer2025Raleigh, North Carolina, United States
Longboard PharmaceuticalsVice President - Head of Business Development2024 — 2025San Diego, California, United States
Oxford BiomedicaVice President - Head of Investor Relations2022 — 2024Raleigh, NC
Raymond JamesDirector2020 — 2022Beverly Hills, California, United States
SVB LeerinkVice President2019 — 2020Charlotte, North Carolina
Cantor FitzgeraldInvestment Banker2016 — 2019New York, New York
RBC Capital MarketsInvestment Banker2014 — 2016New York, New York
Grant Thornton LLPAssociate, Transaction Advisory Services2013 — 2014Charlotte, North Carolina
KPMG USIntern, Asset Management - Hedge Funds/Private Equity2012New York, New York

Skills & more

Mergers & Acquisitions18Due Diligence16Financial Modeling15Financial Statements8Private Equity7Equities5Financial Analysis3Investment Banking1Microsoft Excel1DCFHealthcare Banking

Languages Spanish

From Taylor's professional profile.

Colleagues at Avalo Therapeutics

Aaron Kantoff

Board Member at Avalo Therapeutics

Aaron Kantoff

Managing Partner at Scion Life Sciences

Amy Conrad

Senior Events Manager at Volta Labs

Ashley Ivanowicz

Senior Vice President, Human Resources at Avalo Therapeutics

Chris Sullivan

Chief Financial Officer at Avalo Therapeutics

Colleen Matkowski

Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics

Dino C. Miano

Senior Vice President, CMC and Technical Operations at Avalo Therapeutics

Garrett Lauderdale

Vice President at Idea of La Crosse

Frequently asked questions

Who is Taylor Boyd?: Nearly 15 years of biotech business development, corporate finance, and investment banking experience. Recently served as Executive Vice President and Chief Business Officer at Abzena leading M&A and licensing initiatives. Previously VP and Head of Business Development at Longboard Pharmaceuticals (acquired for $2.6 billion by Lundbeck) and held investment banking roles executing over $40 billion in transactions.
Where does Taylor Boyd work?: Taylor Boyd is Chief Business Officer at Avalo Therapeutics.
Where did Taylor Boyd go to school?: Taylor Boyd studied at Wake Forest University School of Business (Master's degree, Accounting (Transaction Services)); North Carolina State University (Bachelor of Science (B.S.), Accounting); NOLS (Chilean Patagonia).

Same school

Also attended Wake Forest University School of Business32

Casey TierneyInvestor at LegalTech Kaitlin DerrySenior Associate at Brewer Lane Ventures Jake FelmanDirector, Legal at Florida Funders Taylor BryanSenior Associate at Halifax Group Chris MauneyVice President at NovaQuest Capital Management, L.L.C.Larsen MettlerManaging Director at S2G Investments

+ 26 more

Also attended North Carolina State University225

Eric WagnerVP of Research and Data at Redpoint Ventures Taylor AutenGeneral Counsel at Echo Health Ventures Brent BlakeVenture Partner at TFX Capital Bill NusseyPartner at Tech Square Ventures Steve AngelAdvisor at Industrious Ventures Melissa WhitingAssistant Controller at Red Cell Incubation

+ 219 more

Also attended NOLS38

Sidd SrinivasaVenture Partner at Madrona Venture Group Baxter BlackSenior Applied Data Scientist at Madrona Venture Group Chris SaxmanDigital health entrepreneur, startup mentor, skier, fly fisherman, Steelers fanatic, Co-head of Health 2.0 Denver/Boulder Chapter Luis SpradleyPrincipal at Level Equity Maddy DwyerSenior Associate, Business Development at Cross Creek Advisors Alfred JohnsonCEO Partner at Ardent Venture

+ 32 more

Shared employers

Also worked at Oxford Biomedica2

Alex MarshallChief Business Officer at Topas Therapeutics Neill Moray MackenziePartner & EIR at Argobiostudio

Also worked at SVB Leerink27

Sebastian GranizoVenture Capital Associate at Plum Alley Investments John BarrettSenior Analyst, Public Equity at Sofinnova Ventures Ben BurnsideSenior Associate at Heritage Group Isaac RoPartner at Catalio Capital Management, LP Socrates ZachariasPrincipal at BIOSPRING PARTNERS Mark AdamsPartner at Two Bear Capital

+ 21 more

Also worked at Cantor Fitzgerald53

Andy HarrisonGeneral Partner, CEO at S32 Zoe van den BolInvestor at Alpha Partners Jonathan LiAssociate at Questa Capital Jared AndermanManaging Director, Data Analytics at Deerfield Management Company Craig SwansonDirector of Finance at Ospraie Ag Science Andi KazeroonianPrincipal at Outward VC

+ 47 more

Also worked at RBC Capital Markets208

Jaya GuptaInvestor at Foundation Capital Isabella VahdatiPrincipal at Brighteye Ventures Ranieri PaternòPrincipal at Marlin Equity Partners Anna YuInvestor at Spectrum Equity Hunter MerghartVenture Partner at Castle Island Ventures Kyle ReitingerPrincipal at PeakSpan Capital Partners

+ 202 more